A Washington Legal Foundation background document suggests that Congress change direct-to-consumer disclaimer rules to recognize the availability of smartphone technology and QR codes.
Looking to modernize drug and biologic development, FDA seeks industry and public input on how to expand the use of digital health technologies in clinical trials.
A Washington Legal Foundation background document suggests that Congress change direct-to-consumer disclaimer rules to recognize the availability of smartphone technology and QR codes.
Looking to modernize drug and biologic development, FDA seeks industry and public input on how to expand the use of digital health technologies in clinical trials.
FDA warns Henan, China-based Henan Lvyuan Pharmaceutical Company about significant deviations from current good manufacturing practices for active pharmaceutical ingredients.
Researchers at the University of Cincinnati begin a new study to investigate whether widely used diabetes and weight-loss drugs could help prevent or delay Alzheimer’s disease.
